423 related articles for article (PubMed ID: 34040254)
1. Enhancer release and retargeting activates disease-susceptibility genes.
Oh S; Shao J; Mitra J; Xiong F; D'Antonio M; Wang R; Garcia-Bassets I; Ma Q; Zhu X; Lee JH; Nair SJ; Yang F; Ohgi K; Frazer KA; Zhang ZD; Li W; Rosenfeld MG
Nature; 2021 Jul; 595(7869):735-740. PubMed ID: 34040254
[TBL] [Abstract][Full Text] [Related]
2. Interplay between CTCF boundaries and a super enhancer controls cohesin extrusion trajectories and gene expression.
Vos ESM; Valdes-Quezada C; Huang Y; Allahyar A; Verstegen MJAM; Felder AK; van der Vegt F; Uijttewaal ECH; Krijger PHL; de Laat W
Mol Cell; 2021 Aug; 81(15):3082-3095.e6. PubMed ID: 34197738
[TBL] [Abstract][Full Text] [Related]
3. Building regulatory landscapes reveals that an enhancer can recruit cohesin to create contact domains, engage CTCF sites and activate distant genes.
Rinzema NJ; Sofiadis K; Tjalsma SJD; Verstegen MJAM; Oz Y; Valdes-Quezada C; Felder AK; Filipovska T; van der Elst S; de Andrade Dos Ramos Z; Han R; Krijger PHL; de Laat W
Nat Struct Mol Biol; 2022 Jun; 29(6):563-574. PubMed ID: 35710842
[TBL] [Abstract][Full Text] [Related]
4. HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia.
Luo H; Zhu G; Eshelman MA; Fung TK; Lai Q; Wang F; Zeisig BB; Lesperance J; Ma X; Chen S; Cesari N; Cogle C; Chen B; Xu B; Yang FC; So CWE; Qiu Y; Xu M; Huang S
Mol Cell; 2022 Feb; 82(4):833-851.e11. PubMed ID: 35180428
[TBL] [Abstract][Full Text] [Related]
5. Impact of 3D genome organization, guided by cohesin and CTCF looping, on sex-biased chromatin interactions and gene expression in mouse liver.
Matthews BJ; Waxman DJ
Epigenetics Chromatin; 2020 Jul; 13(1):30. PubMed ID: 32680543
[TBL] [Abstract][Full Text] [Related]
6. ZNF143 deletion alters enhancer/promoter looping and CTCF/cohesin geometry.
Zhang M; Huang H; Li J; Wu Q
Cell Rep; 2024 Jan; 43(1):113663. PubMed ID: 38206813
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus.
Wu Y; Jia Z; Ge X; Wu Q
Sci China Life Sci; 2020 Jun; 63(6):835-844. PubMed ID: 32249388
[TBL] [Abstract][Full Text] [Related]
8. Promoter-proximal CTCF binding promotes distal enhancer-dependent gene activation.
Kubo N; Ishii H; Xiong X; Bianco S; Meitinger F; Hu R; Hocker JD; Conte M; Gorkin D; Yu M; Li B; Dixon JR; Hu M; Nicodemi M; Zhao H; Ren B
Nat Struct Mol Biol; 2021 Feb; 28(2):152-161. PubMed ID: 33398174
[TBL] [Abstract][Full Text] [Related]
9. Many facades of CTCF unified by its coding for three-dimensional genome architecture.
Wu Q; Liu P; Wang L
J Genet Genomics; 2020 Aug; 47(8):407-424. PubMed ID: 33187878
[TBL] [Abstract][Full Text] [Related]
10. Tandem CTCF sites function as insulators to balance spatial chromatin contacts and topological enhancer-promoter selection.
Jia Z; Li J; Ge X; Wu Y; Guo Y; Wu Q
Genome Biol; 2020 Mar; 21(1):75. PubMed ID: 32293525
[TBL] [Abstract][Full Text] [Related]
11. Multiple CTCF sites cooperate with each other to maintain a TAD for enhancer-promoter interaction in the β-globin locus.
Kang J; Kim YW; Park S; Kang Y; Kim A
FASEB J; 2021 Aug; 35(8):e21768. PubMed ID: 34245617
[TBL] [Abstract][Full Text] [Related]
12. STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma.
Surdez D; Zaidi S; Grossetête S; Laud-Duval K; Ferre AS; Mous L; Vourc'h T; Tirode F; Pierron G; Raynal V; Baulande S; Brunet E; Hill V; Delattre O
Cancer Cell; 2021 Jun; 39(6):810-826.e9. PubMed ID: 33930311
[TBL] [Abstract][Full Text] [Related]
13. CTCF: the protein, the binding partners, the binding sites and their chromatin loops.
Holwerda SJ; de Laat W
Philos Trans R Soc Lond B Biol Sci; 2013; 368(1620):20120369. PubMed ID: 23650640
[TBL] [Abstract][Full Text] [Related]
14. Variable Extent of Lineage-Specificity and Developmental Stage-Specificity of Cohesin and CCCTC-Binding Factor Binding Within the Immunoglobulin and T Cell Receptor Loci.
Loguercio S; Barajas-Mora EM; Shih HY; Krangel MS; Feeney AJ
Front Immunol; 2018; 9():425. PubMed ID: 29593713
[TBL] [Abstract][Full Text] [Related]
15. Identification of Cancer Drivers at CTCF Insulators in 1,962 Whole Genomes.
Liu EM; Martinez-Fundichely A; Diaz BJ; Aronson B; Cuykendall T; MacKay M; Dhingra P; Wong EWP; Chi P; Apostolou E; Sanjana NE; Khurana E
Cell Syst; 2019 May; 8(5):446-455.e8. PubMed ID: 31078526
[TBL] [Abstract][Full Text] [Related]
16. Disruption of a -35 kb Enhancer Impairs CTCF Binding and
Liu Q; Thoms JAI; Nunez AC; Huang Y; Knezevic K; Packham D; Poulos RC; Williams R; Beck D; Hawkins NJ; Ward RL; Wong JWH; Hesson LB; Sloane MA; Pimanda JE
Clin Cancer Res; 2018 Sep; 24(18):4602-4611. PubMed ID: 29898989
[No Abstract] [Full Text] [Related]
17. Spatial enhancer clustering and regulation of enhancer-proximal genes by cohesin.
Ing-Simmons E; Seitan VC; Faure AJ; Flicek P; Carroll T; Dekker J; Fisher AG; Lenhard B; Merkenschlager M
Genome Res; 2015 Apr; 25(4):504-13. PubMed ID: 25677180
[TBL] [Abstract][Full Text] [Related]
18. Cohesin-Dependent and -Independent Mechanisms Mediate Chromosomal Contacts between Promoters and Enhancers.
Thiecke MJ; Wutz G; Muhar M; Tang W; Bevan S; Malysheva V; Stocsits R; Neumann T; Zuber J; Fraser P; Schoenfelder S; Peters JM; Spivakov M
Cell Rep; 2020 Jul; 32(3):107929. PubMed ID: 32698000
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific CTCF-cohesin-mediated chromatin architecture delimits enhancer interactions and function in vivo.
Hanssen LLP; Kassouf MT; Oudelaar AM; Biggs D; Preece C; Downes DJ; Gosden M; Sharpe JA; Sloane-Stanley JA; Hughes JR; Davies B; Higgs DR
Nat Cell Biol; 2017 Aug; 19(8):952-961. PubMed ID: 28737770
[TBL] [Abstract][Full Text] [Related]
20. Cohesin is required for long-range enhancer action at the Shh locus.
Kane L; Williamson I; Flyamer IM; Kumar Y; Hill RE; Lettice LA; Bickmore WA
Nat Struct Mol Biol; 2022 Sep; 29(9):891-897. PubMed ID: 36097291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
